An evidence-based comparison of two GLP-1 medicines reshaping diabetes and obesity care Key TakeawaysTirzepatide is a dual GIP and GLP-1
If you have spent any time on Indian Instagram, doctor reels, or weekend WhatsApp groups in the last twelve months,
Walk into any clinic in Mumbai, Delhi or Bengaluru today and the same question keeps coming up: if Ozempic and
Plus an evidence-backed look at how tirzepatide compares with semaglutide (Ozempic) for weight loss and Type 2 diabetes Key TakeawaysTirzepatide
Key Takeaways • Semaglutide raises resting heart rate by about 1 to 4 beats per minute on average, based on
Medically reviewed against peer-reviewed clinical research | Updated: May 2026 Key TakeawaysYes, semaglutide is linked to lean mass loss that
Last updated: May 2026 | Reviewed against clinical trial data from STEP 1 to STEP 5 Key TakeawaysMost
A clinically-grounded guide to understanding pancreatitis risk on semaglutide, what the latest 2025 and 2026 data actually show, and how
Medically reviewed health explainer · Last updated: May 2026 Key Takeaways • Semaglutide carries a boxed warning for medullary thyroid
Key Takeaways Gastrointestinal symptoms, mainly nausea, vomiting, and diarrhea, are the most common side effects and typically improve within 4
